Literature DB >> 11149672

Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: a phosphorus magnetic resonance spectroscopy study.

M Rango1, M Bozzali, A Prelle, G Scarlato, N Bresolin.   

Abstract

It remains unclear whether brain energetics is disturbed in patients with mitochondrial disease without clinical central nervous system involvement (MDW). The authors used the high temporal and spatial resolution phosphorus magnetic resonance spectroscopy (31P MRS) technique that they developed to study high energy phosphates (HEPs) and intracellular pH (pH) in the visual cortex of 9 normal subjects and 5 MDW patients with single mtDNA deletion at rest, during, and after visual activation. In normal subjects, HEPs remained unchanged during activation but rose significantly (by 17%) during recovery, and pH increased during visual activation with a slow return to rest values. In MDW patients, HEPs were within the normal range at rest and did not change during activation, but fell significantly (by 22%) in the recovery period; pH did not reveal a homogeneous pattern. In the brain of patients with MDW, energy balance remains normal until oxidative metabolism is intensively stressed, as during a postactivation phase. The heterogeneity of the physicochemical environment (that is, pH) suggests various degrees of subclinical brain involvement. The combined use of MRS and brain activation is fundamental for the study of brain energetics and may prove an important diagnostic tool in patients with MDW.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11149672     DOI: 10.1097/00004647-200101000-00011

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  16 in total

Review 1.  Chronic progressive external ophthalmoplegia.

Authors:  Andrew G Lee; Paul W Brazis
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

2.  Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

Authors:  Dikoma C Shungu; Nora Weiduschat; James W Murrough; Xiangling Mao; Sarah Pillemer; Jonathan P Dyke; Marvin S Medow; Benjamin H Natelson; Julian M Stewart; Sanjay J Mathew
Journal:  NMR Biomed       Date:  2012-01-27       Impact factor: 4.044

3.  Evidence for a relationship between body mass and energy metabolism in the human brain.

Authors:  André Schmoller; Torben Hass; Olga Strugovshchikova; Uwe H Melchert; Harald G Scholand-Engler; Achim Peters; Ulrich Schweiger; Fritz Hohagen; Kerstin M Oltmanns
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-14       Impact factor: 6.200

4.  The brain is hypothermic in patients with mitochondrial diseases.

Authors:  Mario Rango; Andrea Arighi; Cristiana Bonifati; Roberto Del Bo; Giacomo Comi; Nereo Bresolin
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-12       Impact factor: 6.200

5.  Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.

Authors:  William T Regenold; Pornima Phatak; Michael J Makley; Roger D Stone; Mitchel A Kling
Journal:  J Neurol Sci       Date:  2008-09-09       Impact factor: 3.181

6.  Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients.

Authors:  William T Regenold; K Calvin Hisley; Pornima Phatak; Christopher M Marano; Abraham Obuchowski; David M Lefkowitz; Amritpal Sassan; Sameer Ohri; Tony L Phillips; Narveen Dosanjh; Robert R Conley; Rao Gullapalli
Journal:  Bipolar Disord       Date:  2008-11       Impact factor: 6.744

7.  Molecular neurodevelopment: an in vivo 31P-1H MRSI study.

Authors:  Gerald Goldstein; Kanagasabai Panchalingam; Richard J McClure; Jeffrey A Stanley; Vince D Calhoun; Godfrey D Pearlson; Jay W Pettegrew
Journal:  J Int Neuropsychol Soc       Date:  2009-08-13       Impact factor: 2.892

8.  (31)P CSI of the human brain in healthy subjects and tumor patients at 9.4 T with a three-layered multi-nuclear coil: initial results.

Authors:  Christian Mirkes; Gunamony Shajan; Grzegorz Chadzynski; Kai Buckenmaier; Benjamin Bender; Klaus Scheffler
Journal:  MAGMA       Date:  2016-01-25       Impact factor: 2.310

9.  Decreased frontal lobe phosphocreatine levels in methamphetamine users.

Authors:  Young-Hoon Sung; Deborah A Yurgelun-Todd; Xian-Feng Shi; Douglas G Kondo; Kelly J Lundberg; Erin C McGlade; Tracy L Hellem; Rebekah S Huber; Kristen K Fiedler; Renee E Harrell; Bethany R Nickerson; Seong-Eun Kim; Eun-Kee Jeong; Perry F Renshaw
Journal:  Drug Alcohol Depend       Date:  2012-10-18       Impact factor: 4.492

10.  (31)P-MRS using visual stimulation protocols with different durations in healthy young adult subjects.

Authors:  Felipe R Barreto; Thiago B S Costa; Ricardo C G Landim; Gabriela Castellano; Carlos E G Salmon
Journal:  Neurochem Res       Date:  2014-09-17       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.